VedaBio partnered with UCP Merchant Medicine to start important commercial groundwork.
Published
Signal category
Partnerships
Quote
“Partnering with UCP Merchant Medicine today means we are already starting important commercial groundwork”
— Andrea Bryan|VedaBio team
Company
VedaBio
First-in-class molecular diagnostics powered by target-amplification-free CRISPR detection.
- Industry
- Biotechnology Research
- Location
- San Diego, US
- Company size
- 26 employees
VedaBio is building first-in-class diagnostic products designed to deliver rapid, accurate, and accessible testing in decentralized and point-of-need settings. Powered by the company’s CRISPR platform, which is designed to detect targets without the amplification step required by conventional methods, these products represent the next generation of molecular diagnostics, built to bring uncompromising high medical value to the decentralized setting. VedaBio is headquartered in San Diego, California. For more information, visit www.vedabio.com | careers@vedabio.com
Founded 2021